Description
A selective inhibitor of SPHK2 (Kis = 0.4 and> 20 μM for mouse recombinant SPHK2 and SPHK1, respectively); decreases S1P and increases sphingosine levels in U937 monocytic leukemia cells in a concentration-dependent manner; reduces blood levels of S1P in SPHK1-/- but not SPHK2-/- mice; increases blood levels of S1P in wild-type mice and rats
Formal name: (2S)-2-[3-[4-(octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide
Synonyms:
Molecular weight: 453.5
CAS: 1897379-33-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Lipid Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Lipid Biochemistry|Sphingolipids